stockrowMaxCyte, Inc. (MXCT) vs Neuronetics, Inc. (STIM)
- MaxCyte, Inc. MXCT 1.30 −0.76%
- Neuronetics, Inc. STIM 2.18 −10.29%
MaxCyte, Inc. and Neuronetics, Inc. are both Medical Devices companies. Neuronetics, Inc. is the larger, with a market value of $185.2M against $135.2M — 1.4× the size. Neuronetics, Inc. grew revenue faster over the last twelve months: 23.0% against −13.2%. Neuronetics, Inc. has the higher net margin (−14.5% vs −114.8%) and the higher return on invested capital (−16.7% vs −49.2%). Across the 18 metrics below, Neuronetics, Inc. leads on 12 and MaxCyte, Inc. on 6.
Valuation
Profitability
| Metric | MXCT | STIM | Medical Devices median |
|---|---|---|---|
| Gross margin | 79.23% | 50.68% | 57.76% |
| Operating margin | (134.59%) | (9.39%) | (15.07%) |
| Net margin | (114.77%) | (14.45%) | (14.45%) |
| Free cash flow margin | (76.14%) | (5.18%) | (3.88%) |
| Return on equity | (20.39%) | (85.85%) | (10.35%) |
| Return on assets | (17.62%) | (16.64%) | (17.26%) |
| Return on invested capital | (49.23%) | (16.72%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack